AELIX announces ‘important step towards HIV eradication’
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies…
February 24, 2023 - 4 minutes
Clinical trial
Depression trial gets green light
Beckley Psytech Ltd has received investigational new drug (IND) approval from the U.S. Food and…
February 23, 2023 - 3 minutes
Positive topline data from sepsis trial
Modus Therapeutics AB has published positive top-line data from its phase 1b lipopolysaccharide (LPS) provocation…
February 23, 2023 - 3 minutes
First patient enrolled in Pharming APSD trial
Pharming Group N.V. says the first patient has been enrolled in its phase III clinical…
February 21, 2023 - 6 minutes
Positive results for INOVIO recurrent respiratory papillomatosis trial
INOVIO Pharmaceuticals has announced positive preliminary results from the second cohort of its phase 1/2…
February 17, 2023 - 3 minutes
Immuno Cure starts HIV drug trial
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park,…
February 17, 2023 - 3 minutes
Report: China leads the way with phase 1 studies
Novotech, an Asia Pacific biotech CRO, has published a new global report on phase 1…
February 17, 2023 - 3 minutes
Newron reports ‘striking’ schizophrenia study results
Newron Pharmaceuticals S.p.A. has announced what it says are ‘very exciting new results’ from the…
February 16, 2023 - 5 minutes
Bladder cancer investigational therapy may be given at home
UroGen Pharma Ltd. has announced preliminary results of a study to assess the feasibility of…
February 16, 2023 - 4 minutes
Cytovation melanoma study under way
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its…
February 16, 2023 - 2 minutes
IMV presents positive lymphoma trial results
IMV Inc. has announced positive preliminary data from its VITALIZE phase 2B trial. The study…
February 14, 2023 - 3 minutes
Minoryx Therapeutics announces X-linked adrenoleukodystrophy data
Minoryx Therapeutics has announced that data from its phase 2/3 ADVANCE clinical trial of lead…
February 14, 2023 - 4 minutes
